Osteopenia, Osteoporosis
11
1
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
Senolytics to Improve Osteoporosis Therapy
Romosozumab in Women With Chronic SCI
Functional and Metabolic Effects of Fonte Fausta® Water on Bone and Muscle Health in Osteoporotic Patients
Periprosthetic Plate Over Humeral Nail
Physical Activity and Disability Prevention in Postmenopausal Women
Utilizing Protein During Weight Loss to Impact Physical Function and Bone
Intervention Study of Drugs in Patients Osteopenia and Osteoporosis
Effects of Physical Exercise on Postmenopausal Risk Factors in Women With Osteopenia
Prevalence of Sarcopenia and Sarcopenic Obesity in Older Adults
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study
A Study of Changes in Bone Mineral Density as a Function of Consuming Two Different Forms of Calcium Carbonate